P18.13.A DE-NOVO PURINE METABOLISM CAN BE TARGETED SAFELY IN GLIOBLASTOMA TREATMENT TO OVERCOME CHEMORADIATION RESISTANCE: AN INTERIM RESULT OF PHASE 0/1 CLINICAL TRIAL

Y Umemura, N Clarke, W Al-Holou,A L Elaimy, A Scott,D Leung, M Kim, S Ferris, J Thomas,J Heth,M Schipper, K Suresh,T Lawrence, D Wahl

Neuro-Oncology（2024）

Cited 0|Views0

No score

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined